Deals
Dassault Eyes U.S. Acquisitions Including Medidata
- French tech firm interested in clinical-trial software company
- Dassault scouting U.S. targets, no final decision made on bid
Dassault Systemes headquarters in Velizy, France.
Photographer: Fabrice Dimier/BloombergThis article is for subscribers only.
French technology company Dassault Systemes SE is seeking U.S. acquisitions and considering targets including Medidata Solutions Inc., a software firm focused on clinical trials, according to people familiar with the matter. Medidata’s shares rose.
Dassault is discussing the potential purchase of Medidata to bolster its life science unit, said the people, who asked not to be identified because the matter isn’t public. Deliberations are preliminary and the French software maker may decide against proceeding with a takeover or opt for a different company, they said. Medidata could also draw interest from other suitors, one of the people said.